These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32601971)
1. CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA. Yang X; Zhao L; Pei J; Wang Z; Zhang J; Wang B Breast Cancer Res Treat; 2020 Aug; 183(1):71-82. PubMed ID: 32601971 [TBL] [Abstract][Full Text] [Related]
2. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway. Zheng SR; Huang QD; Zheng ZH; Zhang ZT; Guo GL J Biochem; 2021 Jul; 169(5):601-611. PubMed ID: 33481008 [TBL] [Abstract][Full Text] [Related]
3. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Blanchard Z; Paul BT; Craft B; ElShamy WM Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO. Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453 [TBL] [Abstract][Full Text] [Related]
5. A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line. Lasham A; Mehta SY; Fitzgerald SJ; Woolley AG; Hearn JI; Hurley DG; Ruza I; Algie M; Shelling AN; Braithwaite AW; Print CG Int J Cancer; 2016 Sep; 139(5):1157-70. PubMed ID: 27072400 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer. Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638 [TBL] [Abstract][Full Text] [Related]
7. CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer. Zhao Y; Yu Y; Li X; Guo A J Exp Clin Cancer Res; 2024 Apr; 43(1):115. PubMed ID: 38627816 [TBL] [Abstract][Full Text] [Related]
8. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
9. LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP. Lai H; Wang R; Li S; Shi Q; Cai Z; Li Y; Liu Y Sci China Life Sci; 2020 Mar; 63(3):419-428. PubMed ID: 31420851 [TBL] [Abstract][Full Text] [Related]
10. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP]. Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
12. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer. Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269 [TBL] [Abstract][Full Text] [Related]
13. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction. Chen F; Luo N; Hu Y; Li X; Zhang K Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PCAT29 regulates the growth, migration and invasion of human triple-negative breast cancer cells. Lu C; Li HL; Zhang X; Zhao J; Zheng WH J BUON; 2020; 25(2):621-626. PubMed ID: 32521844 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis. Zhao PW; Cui JX; Wang XM Pharmacogenomics J; 2024 Feb; 24(2):5. PubMed ID: 38378770 [TBL] [Abstract][Full Text] [Related]
16. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 Up-Regulation Mediates Taxane Resistance Downstream of APC Loss. Wise AR; Maloney S; Hering A; Zabala S; Richmond GE; VanKlompenberg MK; Nair MT; Prosperi JR Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928449 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2. Liu M; Gong C; Xu R; Chen Y; Wang X Cell Mol Biol Lett; 2019; 24():47. PubMed ID: 31308851 [TBL] [Abstract][Full Text] [Related]
19. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431 [TBL] [Abstract][Full Text] [Related]
20. RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21. Liu G; Zhang Q; Xia L; Shi M; Cai J; Zhang H; Li J; Lin G; Xie W; Zhang Y; Xu N Cell Death Dis; 2019 Sep; 10(10):688. PubMed ID: 31534127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]